The Institute of Cancer Research has outlined its position on a number of policy issues in scientific and medical research. Our statements can be read and downloaded here.
The ICR believe Big Data has the potential to transform the cancer research landscape. To properly seize the opportunities offered, we need new approaches to data collection, curation and analysis, and support for infrastructure, education and training.
The ICR believe it is essential for UK science that we can continue to welcome researchers from across the UK and worldwide to work in this country.
The ICR believe the EU’s system of paediatric investigational plans (PIPs) needs to be revised to ensure cancer drugs developed for adults are also tested in children whenever their mechanism of action suggests they could be effective.
A statement on the regulation and transparency of clinical trials from The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust.
Patient data must be stored safely to ensure patient confidentiality, but such safeguards must not hamper access to patient data for research use.
Genetic information should be routinely used to inform people with cancer about their risk and help to guide decisions over personalised cancer treatment.
The ICR believes that life-extending therapies are an important step towards our ultimate aim – which is not only to control cancers, but to cure them.
The ICR believes that animal research is essential to understand how cancer develops and behaves within a whole organism and how to treat it effectively.
Our report asks how we can best harness advances in science to bring innovative drugs to patients. It is designed to help us reshape the landscape for drug discovery and development – and create tomorrow’s cancer treatments.
Contact us to find out more about the ICR.